Applied Genetic Technologies Corporation (AGTC) is an organization with strong values of responsibility and integrity. Our written standards and policies contain guidelines designed to ensure the highest standards of ethics and compliance.
AGTC is also committed to an environment where open, honest communications are the expectation, not the exception. We want you to feel comfortable in approaching your supervisor or management in instances where you believe violations of policies or standards have occurred.
In situations where you prefer to place an anonymous report in confidence, you may make a report using the Ethics and Compliance Hotline, hosted by NASDAQ as a third party hotline provider.
You may use any of the following two methods to submit a report:
The information you provide will be sent to the Chair of AGTC’s Audit Committee and AGTC’s legal department on a totally confidential and anonymous basis if you should choose. You have our guarantee that your comments and concerns will be heard.
AGTC is now pre-screening for a phase 2/3 clinical trial of an investigational gene therapy in people with X-Linked Retinitis Pigmentosa.
Learn more about the clinical trial or how to qualify for pre-screening: